• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 69-83 of 131 results

1005 Exhibit: Ex 1005 Liversidge et al, US Patent No 5,399,363

Document IPR2017-01100, No. 1005-4 Exhibit - Ex 1005 Liversidge et al, US Patent No 5,399,363 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1027 Exhibit: Ex 1027 List et al, US Patent No 5,389,382

Document IPR2017-01100, No. 1027-26 Exhibit - Ex 1027 List et al, US Patent No 5,389,382 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1008 Exhibit: Ex 1008 Physicians Desk Reference 307, 682 85 49th ed 1995 Taxolp...

Document IPR2017-01100, No. 1008-33 Exhibit - Ex 1008 Physicians Desk Reference 307, 682 85 49th ed 1995 Taxolpaclitaxel for Injection Concentrate (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1029 Exhibit: Ex 1029 Noureddini et al, Densities of Vegetable Oils and Fatty Acids...

Document IPR2017-01100, No. 1029-28 Exhibit - Ex 1029 Noureddini et al, Densities of Vegetable Oils and Fatty Acids, 69 JAOCS 1184 Dec 1992 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1018 Exhibit: Ex 1018 US Application No 11520,479, Amendment in Response to N...

Document IPR2017-01100, No. 1018-17 Exhibit - Ex 1018 US Application No 11520,479, Amendment in Response to Non Final Office Action dated Sept 30, 2010 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1014 Exhibit: Ex 1014 Grinstaff et al, US Patent No 5,498,421

Document IPR2017-01100, No. 1014-13 Exhibit - Ex 1014 Grinstaff et al, US Patent No 5,498,421 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1015 Exhibit: Ex 1015 Patient Information Leaflet, ABRAXANE for Injectable Suspe...

Document IPR2017-01100, No. 1015-14 Exhibit - Ex 1015 Patient Information Leaflet, ABRAXANE for Injectable Suspension paclitaxel protein bound particles for injectable suspension albumin bound rev...

cite Cite Document
Analyze

1002 Exhibit: Ex 1002 Declaration Of Cory J Berkland, PhD

Document IPR2017-01100, No. 1002-35 Exhibit - Ex 1002 Declaration Of Cory J Berkland, PhD (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1026 Exhibit: Ex 1026 US Pharmacopoeia 23 1995 ed excerpted USP

Document IPR2017-01100, No. 1026-25 Exhibit - Ex 1026 US Pharmacopoeia 23 1995 ed excerpted USP (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1004 Exhibit: Ex 1004 Shively, US Patent No 5,407,683

Document IPR2017-01100, No. 1004-3 Exhibit - Ex 1004 Shively, US Patent No 5,407,683 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1023 Exhibit: Ex 1023 US Application No 11520,479, Amendment in Response to N...

Document IPR2017-01100, No. 1023-22 Exhibit - Ex 1023 US Application No 11520,479, Amendment in Response to Non Final Office Action dated Nov 1, 2013 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1024 Exhibit: Ex 1024 US Application No 11520,479, Supplemental Declaration of N...

Document IPR2017-01100, No. 1024-23 Exhibit - Ex 1024 US Application No 11520,479, Supplemental Declaration of Neil P Desai Pursuant to 37 CFR 1132 dated Nov 1, 2013 2nd Inventor Declaration (P...

cite Cite Document
Analyze

1033 Exhibit: Ex 1033 Indian Patent Application No 2899DELNP2005, Applicants R...

Document IPR2017-01100, No. 1033-32 Exhibit - Ex 1033 Indian Patent Application No 2899DELNP2005, Applicants Response to First Examination Report Jan 6, 2009 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1010 Exhibit: Ex 1010 EMEA Guidance on Manufacture of the Finished Dosage For...

Document IPR2017-01100, No. 1010-9 Exhibit - Ex 1010 EMEA Guidance on Manufacture of the Finished Dosage Form April 1996 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1034 Exhibit: Ex 1034 Declaration Of Edmund J Elder, Jr, PhD, RPh

Document IPR2017-01100, No. 1034-34 Exhibit - Ex 1034 Declaration Of Edmund J Elder, Jr, PhD, RPh (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 7 8 9 10 >>